Antiviral agents and HIV prevention
Preventing the formation of positive transcription elongation factor b by human cyclin T1-binding RNA aptamer for anti-HIV transcription
Memory B-cell depletion is a feature of HIV-2 infection even in the absence of detectable viremia
E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure
Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens
Clinical significance of lipoarabinomannan detection in urine using a low-cost point-of-care diagnostic assay for HIV-associated tuberculosis
Increased regression and decreased incidence of human papillomavirus-related cervical lesions among HIV-infected women on HAART
Virological responses during treatment for recent hepatitis C virus
Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa
CCR5 antagonists
High rate of K65R for antiretroviral therapy-naive patients with subtype C HIV infection failing a tenofovir-containing first-line regimen
Early antiretroviral therapy improves neurodevelopmental outcomes in infants
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study
Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals
Viral load monitoring in resource-limited settings
Hepatitis C virus genotype 4 responds better to pegylated interferon with ribavirin than genotype 1 in HIV-infected patients
Immunoglobulin A-dominant postinfectious glomerulonephritis in a patient with acute HIV syndrome
Central nervous system HIV replication and HIV-related pachymeningitis in a patient on protease inhibitor monotherapy despite an undetectable plasma viral load
Response to Lawn et al.
Assessing the impact of prevalent tuberculosis on mortality among antiretroviral treatment initiators
The evolving epidemiology of HIV/AIDS